Nuevo%2520logo%2520Emergpharma_edited_ed

Follow us on:

Search

Biosimilars following same pattern as generics? Neupogen keeps just 6% of EU market after 10 years.

Aug 11, 2019

Biosimilars following same pattern as generics? Neupogen keeps just 6% of EU market after 10 years.

Twelve years after the launch of the first biosimilar in Europe, there are still limited data available on the medium-term impact of the...

Parallel trading get 30% of branded products to Big Pharma in German market after patent expiration.

May 23, 2019

Parallel trading get 30% of branded products to Big Pharma in German market after patent expiration.

A sub-study from the report “German generics market 2016-2018” recently published by Emergpharma shows interesting facts regarding the...

Notes on the German generics and biosimilars market 2016-2018.

May 8, 2019

Notes on the German generics and biosimilars market 2016-2018.

German generics market is the biggest in Europe in terms of values and units. It is also one of the most dynamic and with the largest...

Subscribe to keep updated about our most recent original articles and publications.